These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11753543)

  • 1. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis.
    Klein JP; Rizzo JD; Zhang MJ; Keiding N
    Bone Marrow Transplant; 2001 Nov; 28(10):909-15. PubMed ID: 11753543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modeling.
    Klein JP; Rizzo JD; Zhang MJ; Keiding N
    Bone Marrow Transplant; 2001 Dec; 28(11):1001-11. PubMed ID: 11781608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of summary survival curve data.
    Arends LR; Hunink MG; Stijnen T
    Stat Med; 2008 Sep; 27(22):4381-96. PubMed ID: 18465839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A partially parametric estimator of survival in the presence of randomly censored data.
    Klein JP; Lee SC; Moeschberger ML
    Biometrics; 1990 Sep; 46(3):795-811. PubMed ID: 2242415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression modeling of competing risks data based on pseudovalues of the cumulative incidence function.
    Klein JP; Andersen PK
    Biometrics; 2005 Mar; 61(1):223-9. PubMed ID: 15737097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival analysis techniques in clinical research.
    Myers J
    J Ky Med Assoc; 2007 Nov; 105(11):545-50. PubMed ID: 18183806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow transplantation in adults with thalassemia: Treatment and long-term follow-up.
    Gaziev J; Sodani P; Polchi P; Andreani M; Lucarelli G
    Ann N Y Acad Sci; 2005; 1054():196-205. PubMed ID: 16339666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A weighted Kaplan-Meier estimator for matched data with application to the comparison of chemotherapy and bone-marrow transplant in leukaemia.
    Galimberti S; Sasieni P; Valsecchi MG
    Stat Med; 2002 Dec; 21(24):3847-64. PubMed ID: 12483771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
    Bacigalupo A; Sormani MP; Lamparelli T; Gualandi F; Occhini D; Bregante S; Raiola AM; di Grazia C; Dominietto A; Tedone E; Piaggio G; Podesta M; Bruno B; Oneto R; Lombardi A; Frassoni F; Rolla D; Rollandi G; Viscoli C; Ferro C; Garbarino L; Van Lint MT
    Haematologica; 2004 Oct; 89(10):1238-47. PubMed ID: 15477210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical evaluation of bone marrow transplantation data.
    Szydło RM
    Arch Immunol Ther Exp (Warsz); 1995; 43(2):107-10. PubMed ID: 8744724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
    Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
    Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing survival curves at a fixed point in time.
    Klein JP; Logan B; Harhoff M; Andersen PK
    Stat Med; 2007 Oct; 26(24):4505-19. PubMed ID: 17348080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Kaplan-Meier analysis].
    Tripepi G; Catalano F
    G Ital Nefrol; 2004; 21(6):540-6. PubMed ID: 15593021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing treatments in the presence of crossing survival curves: an application to bone marrow transplantation.
    Logan BR; Klein JP; Zhang MJ
    Biometrics; 2008 Sep; 64(3):733-740. PubMed ID: 18190619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry.
    del Cañizo MC; Martínez C; Conde E; Vallejo C; Brunet S; Sanz G; Mateos MV;
    Bone Marrow Transplant; 2003 Nov; 32(10):987-92. PubMed ID: 14595386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of time to death after transplantation when transplants are only given to patients in remission.
    Stram DO; Sather H; Wang L
    Biometrics; 1996 Sep; 52(3):1079-86. PubMed ID: 8805769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of autologous and allogeneic blood or marrow transplantation for mantle cell lymphoma.
    Kasamon YL; Jones RJ; Diehl LF; Nayer H; Borowitz MJ; Garrett-Mayer E; Ambinder RF; Abrams RA; Zhang Z; Flinn IW
    Biol Blood Marrow Transplant; 2005 Jan; 11(1):39-46. PubMed ID: 15625543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pairwise multiple comparison adjustment in survival analysis.
    Logan BR; Wang H; Zhang MJ
    Stat Med; 2005 Aug; 24(16):2509-23. PubMed ID: 15977296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.